| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | USPH U S Physical Therapy Inc /nv | Chapman Harry S58 | Director | Sell | 8,600 | $90.82 | $781,052.00 | -38.2% | +11.2% | -3.5% | |
| Dec 2, 2022 | UNH Unitedhealth Group Inc | McSweeney Erin50 | EVP Chief People Officer | Sell | 616 | $535.00 | $329,560.00 | -6.8% | -10.9% | +3.6% | |
| Dec 2, 2022 | USPH U S Physical Therapy Inc /nv | Reading Christopher J68 | Chief Executive Officer | Sell | 10,000 | $90.01 | $900,100.00 | -11.2% | +11.2% | -3.5% | |
| Dec 2, 2022 | RHEP Regional Health Properties, Inc | Frischer Charles L78 | 10% Owner | Buy | 12,272 | $1.67 | $20,494.24 | +3.1% | - | - | |
| Dec 2, 2022 | OSCR Oscar Health, Inc. | Blackley Richard Scott56 | Chief Transformation Officer | Sell | 3,369 | $2.84 | $9,554.48 | -1.1% | +66.3% | +198.2% | |
| Dec 2, 2022 | OSCR Oscar Health, Inc. | Bopitiya Ranmali48 | EVP &Chief Legal Officer | Sell | 6,281 | $2.84 | $17,812.92 | -12.8% | +66.3% | +198.2% | |
| Dec 2, 2022 | OSCR Oscar Health, Inc. | Weaver Dennis58 | Chief Clinical Officer | Sell | 1,624 | $2.84 | $4,605.66 | -5.7% | +66.3% | +198.2% | |
| Dec 2, 2022 | OSCR Oscar Health, Inc. | Baltrus Victoria47 | Chief Accounting Officer | Sell | 2,789 | $2.84 | $7,909.60 | -11.9% | +66.3% | +198.2% | |
| Dec 2, 2022 | OSCR Oscar Health, Inc. | Quane Alessandrea C.51 | EVP, Chief Insurance Officer | Sell | 3,813 | $2.84 | $10,813.67 | -2.4% | +66.3% | +198.2% | |
| Dec 2, 2022 | USPH U S Physical Therapy Inc /nv | Trier Clayton66 | Director | Sell | 2,740 | $88.48 | $242,430.60 | -9.6% | +11.2% | -3.5% | |
| Dec 1, 2022 | ALHC Alignment Healthcare, Inc. | Kumar Dinesh M.84 | Chief Med &Operating Officer | Sell | 20,000 | $13.08 | $261,572.00 | -1.7% | -38.3% | -43.4% | |
| Dec 1, 2022 | PGNY Progyny, Inc. | Livingston Mark S.83 | Chief Financial Officer | Sell | 2,997 | $36.46 | $109,270.62 | -4.8% | +4.0% | -5.9% | |
| Dec 1, 2022 | DGX Quest Diagnostics Inc | Ring Timothy M53 | Director | Sell | 2,025 | $152.50 | $308,812.50 | -7.7% | -8.9% | -10.8% | |
| Dec 1, 2022 | ALHC Alignment Healthcare, Inc. | Freeman Robert Thomas58 | Chief Financial Officer | Sell | 24,000 | $13.10 | $314,445.60 | -4.4% | -38.3% | -43.4% | |
| Dec 1, 2022 | ALHC Alignment Healthcare, Inc. | Kao John E68 | Chief Executive Officer | Sell | 25,000 | $13.11 | $327,777.50 | -0.9% | -38.3% | -43.4% | |
| Nov 30, 2022 | ADUS Addus Homecare Corp | Tucker David W.64 | EVP / Chief Strategy Officer | Sell | 784 | $108.57 | $85,118.88 | -9.9% | -1.5% | -20.9% | |
| Nov 30, 2022 | PNTG Pennant Group, Inc. | Nackel John G. | - | Buy | 20,000 | $10.13 | $202,600.00 | +31.9% | +45.3% | +32.7% | |
| Nov 29, 2022 | PGNY Progyny, Inc. | Livingston Mark S.83 | Chief Financial Officer | Sell | 14,801 | $36.70 | $543,196.70 | -18.8% | -15.1% | -7.1% | |
| Nov 28, 2022 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | SVP, Regional Businesses | Sell | 40,765 | $149.18 | $6,081,261.97 | -20.4% | -7.0% | -9.0% | |
| Nov 28, 2022 | CCRN Cross Country Healthcare Inc | Grieco Cynthia Ann70 | VP, Corporate Treasurer | Sell | 1,071 | $36.00 | $38,556.00 | -8.2% | -23.7% | -41.7% | |
| Nov 28, 2022 | ADUS Addus Homecare Corp | Tucker David W.64 | EVP / Chief Strategy Officer | Sell | 268 | $107.09 | $28,700.12 | -3.3% | -2.1% | -17.6% | |
| Nov 23, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 6,617 | $34.25 | $226,632.25 | -2.2% | -7.9% | +0.5% | |
| Nov 22, 2022 | ADUS Addus Homecare Corp | Bickham W Bradley61 | President And COO | Sell | 7,500 | $105.21 | $789,075.00 | -16.0% | -2.2% | -17.6% | |
| Nov 22, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 6,617 | $33.80 | $223,654.60 | -2.1% | -6.8% | -0.4% | |
| Nov 21, 2022 | CHE Chemed Corp | McNamara Kevin J57 | President And CEO | Sell | 2,000 | $505.76 | $1,011,520.00 | -1.6% | +1.3% | +14.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.